InvestingZone Chairman to Speak at Chemistry Means Business 2017

Chairman of InvestingZone and Chief Executive Office of Acceleris Capital, Norman Molyneux, is today appearing at the Royal Society of Chemistry Access to Finance Event.

The panel will include rich discussion on the funding environment for SMEs across the UK, local providers of finance and the value of the AIM market.

The panel will then explore investment readiness and what a good investment story should look like.

Sitting alongside Deepridge, the London Stock Exchange and Immupharma plc, Norman will be representing the effectiveness of professional corporate finance support for UK SMEs when embarking on a strategy for growth.

Chemistry Means Business is the Royal Society of Chemistry’s annual flagship event for the industry, bringing together start-ups, small and medium enterprises, multinational organisations, and academic entrepreneurs from across the UK and Europe.

Stay Connected

REGISTERED OFFICE

This website page has been approved as a financial promotion for the purposes of section 21 of the Financial Services and Markets Act 2000.

Investing in securities issued by smaller, early stage companies involves risk, including loss of capital, illiquidity, lack of dividends and dilution and it should only be undertaken by persons who are capable of understanding the risks involved in such an investment and who are able to bear the loss of their investment. The InvestingZone website and potential investments are each directed solely at experienced, sophisticated investors who are capable of understanding the risks involved and you must ensure that you fully understand these risks before investing and take independent advice from a suitably qualified professional. InvestingZone is not able to provide advice as to the merits or otherwise of any investment.